elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q30412791-83682D66-534F-40AA-953F-237B191D60F7
Q30412791-83682D66-534F-40AA-953F-237B191D60F7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30412791-83682D66-534F-40AA-953F-237B191D60F7
A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma
P2860
Q30412791-83682D66-534F-40AA-953F-237B191D60F7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30412791-83682D66-534F-40AA-953F-237B191D60F7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a7d0e83422e56dcd9f7c07ec3d92e57c0ed33ed
P2860
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer